Arsenic Trioxide 10mg injection

Arsenic Trioxide 10mg injection

11200.0 INR/Pack

Product Details:

  • Drug Type Injection
  • Physical Form Liquid
  • Recommended For Doctor
  • Dosage Guidelines As per Instructions
  • Suitable For Adults
  • Storage Instructions Cool & Dry Place
  • Click to view more
X

Arsenic Trioxide 10mg injection Price And Quantity

  • 11200.0 INR/Pack
  • 19 Pack

Arsenic Trioxide 10mg injection Product Specifications

  • Doctor
  • Adults
  • Cool & Dry Place
  • Liquid
  • Injection
  • As per Instructions

Arsenic Trioxide 10mg injection Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
  • 250 Pack Per Week
  • 4 Days
  • No
  • If order is confirmed we will reimburse the sample cost
  • Africa, Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East
  • All India

Product Description

1. Technical Specifications

Attribute Details
Brand Name Trisenox / Arsenic Trioxide Injection (generic)
Generic Name Arsenic trioxide
Strength 10 mg per vial (10 mL vial; concentration 1 mg/mL)
Dosage Form Intravenous infusion (concentrate for dilution)
Packaging Size Single-dose vial (10 mL)
Packaging Type Glass vial with rubber stopper & flip-off seal
Medicine Type Antineoplastic / Differentiating agent
Manufacturer Janssen, Teva, Fresenius Kabi, and other oncology manufacturers
Distributed By Authorized oncology distributors / hospital pharmacies

2. Product Description

Arsenic trioxide is an antineoplastic agent used in the treatment of acute promyelocytic leukemia (APL). It induces apoptosis and promotes the differentiation of malignant promyelocytes. It is particularly effective in relapsed or refractory cases and is also used in some frontline regimens in combination with ATRA.


3. Product Highlights

Attribute Details
Therapeutic Category Antineoplastic / Differentiating agent
Application Area Acute Promyelocytic Leukemia (APL)
Mechanism of Action Induces apoptosis and degrades the PML-RAR oncoprotein; promotes differentiation of malignant promyelocytes
Administration Intravenous infusion (dilute in IV fluid, infuse over 12 hours)
Storage Conditions Store at 28 C, protect from light, do not freeze; follow stability instructions for diluted solution

4. Therapeutic Uses

  • Treatment of relapsed or refractory APL

  • Used in combination with ATRA in certain frontline regimens


5. Dosage & Administration

  • Induction: 0.15 mg/kg IV once daily until bone marrow remission or for a maximum of 60 days

  • Consolidation: 0.15 mg/kg IV once daily for 25 doses over 5 weeks (5 days per week), beginning 36 weeks after induction

  • Infusion: Dilute with suitable IV fluid; infuse over 12 hours

  • Adjustments: Interrupt or modify dosage for grade 3 toxicity, cardiac arrhythmia, or organ dysfunction


6. Side Effects

Common:

  • Nausea, vomiting, diarrhea, fatigue, fever

  • Myelosuppression: anemia, neutropenia, thrombocytopenia

  • Elevated liver enzymes

Serious:

  • Differentiation syndrome (APL syndrome): fever, dyspnea, pulmonary infiltrates, hypotension, renal failure (requires immediate corticosteroid treatment)

  • QT prolongation and arrhythmias: risk of torsades de pointes; requires ECG and electrolyte monitoring

  • Electrolyte imbalances: hypokalemia, hypomagnesemia

  • Rare: hepatotoxicity, pancreatitis, pulmonary toxicity


7. Precautions & Monitoring

  • Monitor ECG and electrolytes (K, Mg, Ca) before and during treatment

  • Frequent CBC, liver, and renal function tests

  • Watch for early signs of differentiation syndrome; initiate steroids promptly if suspected

  • Avoid in pregnancy (teratogenic) advise effective contraception

  • Avoid concomitant drugs that prolong QT interval when possible

  • Administer only in a facility with proper oncology monitoring and resuscitation support


8. Handling & Disposal

  • Handle with cytotoxic precautions: gloves, gowns, and safety cabinets during preparation

  • Dispose of vials, syringes, and contaminated materials as per hazardous cytotoxic waste guidelines



Precision in Oncology Care

Arsenic Trioxide 10mg injection plays a pivotal role in specific cancer treatments. It is tailored for adults and is dispensed to healthcare institutions and certified distributors across India. Trusted by medical professionals, it adheres to stringent safety standards and is manufactured to ensure optimal therapeutic outcomes.


Stringent Storage & Handling

To preserve its integrity, Arsenic Trioxide injection should be kept in a cool and dry environment. Proper storage helps maintain its effectiveness and ensures patient safety. Medical facilities and distributors are advised to follow official guidelines for storage and transportation.

FAQs of Arsenic Trioxide 10mg injection:


Q: How should Arsenic Trioxide 10mg injection be administered?

A: Arsenic Trioxide 10mg injection is administered intravenously by a doctor or qualified healthcare professional in a clinical setting, following precise dosage and safety guidelines set by the prescribing physician.

Q: What is the primary use of Arsenic Trioxide 10mg injection?

A: This injection is primarily used for the treatment of certain cancers, such as acute promyelocytic leukemia, under the supervision of a healthcare provider.

Q: When is this medication recommended for use?

A: Arsenic Trioxide 10mg injection is recommended when a patient is diagnosed with specific conditions as determined by a doctor, who will decide when and how treatment should proceed.

Q: Where should Arsenic Trioxide 10mg injection be stored?

A: It must be stored in a cool and dry place, away from direct sunlight and moisture, to ensure the medication remains stable and effective until use.

Q: What is the process for obtaining this injection in India?

A: Licensed distributors, exporters, suppliers, traders, and wholesalers in India handle the distribution of Arsenic Trioxide 10mg injection, making it available to certified hospitals and clinics.

Q: How does following proper storage instructions benefit this medication?

A: Adhering to recommended storage conditions preserves the injections potency and safety, ensuring maximum therapeutic benefit for patients.

Q: Who is suitable to receive Arsenic Trioxide 10mg injection therapy?

A: This medication is suitable for adult patients and must be prescribed and administered by a healthcare professional with experience in oncology treatments.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anticancer medicine' category



Back to top